0 0 0 0 0 0 0.00168241232043478 0.00634140028471586
Thanks for submitting the form.
Stockreport

Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Developments [Yahoo! Finance]

Incyte Corporation (INCY)  More Company Research Source: Yahoo! Finance
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
Research and Development Expenses: $40.5 million for Q3 2024, up from $30.1 million in Q3 2023. Selling, General and Administrative Expenses: $14.1 million for Q3 2024, compared to $12.4 million in Q3 2023. Cash, Cash Equivalents, and Marketable Securities: $200.4 million as of September 30, 2024, compared to $229.8 million as of December 31, 2023. Milestone Payments: $100 million received from Incyte in August 2024. Warning! GuruFocus has detected 4 Warning Signs with MGNX. Release Date: November 05, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Macrogenics Inc ( NASDAQ:MGNX ) reported a significant increase in total revenue to $110.7 million for Q3 2024, primarily due to $100 million in milestones from Incyte. The company achieved a net income of $56.3 million for Q3 2024, a substantial increase from $17.6 million in Q3 2023. Macrogenics Inc ( NASDAQ:MGNX ) has a strong cash position with $200.4 million in [Read more]

IMPACT SNAPSHOT EVENT TIME: INCY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Stockreport

Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Developments [Yahoo! Finance]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
Research and Development Expenses: $40.5 million for Q3 2024, up from $30.1 million in Q3 2023. Selling, General and Administrative Expenses: $14.1 million for Q3 2024, compared to $12.4 million in Q3 2023. Cash, Cash Equivalents, and Marketable Securities: $200.4 million as of September 30, 2024, compared to $229.8 million as of December 31, 2023. Milestone Payments: $100 million received from Incyte in August 2024. Warning! GuruFocus has detected 4 Warning Signs with MGNX. Release Date: November 05, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Macrogenics Inc ( NASDAQ:MGNX ) reported a significant increase in total revenue to $110.7 million for Q3 2024, primarily due to $100 million in milestones from Incyte. The company achieved a net income of $56.3 million for Q3 2024, a substantial increase from $17.6 million in Q3 2023. Macrogenics Inc ( NASDAQ:MGNX ) has a strong cash position with $200.4 million in [Read more]

IMPACT SNAPSHOT
EVENT TIME:
INCY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS